Keybank National Association Vertex Pharmaceuticals Inc Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Keybank National Association holds 11,971 shares of VRTX stock, worth $6.01 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,971

Previous 13,665 12.4%

Holding current value

$6.01 Million

Previous $6.41 Million 13.08%

% of portfolio

0.02%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$460.0 - $505.78 $779,240 - $856,791	-1,694 Reduced 12.4%	11,971 $5.57 Million
Q2 2024 Jul 31, 2024	BUY	$392.81 - $485.53 $256,112 - $316,565	652 Added 5.01%	13,665 $6.41 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $318,405 - $348,388	-781 Reduced 5.66%	13,013 $5.44 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $279,202 - $334,293	-814 Reduced 5.57%	13,794 $5.61 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $8,454 - $9,061	-25 Reduced 0.17%	14,608 $5.08 Million
Q2 2023 Aug 01, 2023	SELL	$314.42 - $351.91 $29,869 - $33,431	-95 Reduced 0.65%	14,633 $5.15 Million
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $224,601 - $256,218	-793 Reduced 5.11%	14,728 $4.64 Million
Q4 2022 Jan 31, 2023	SELL	$285.76 - $321.48 $197,460 - $222,142	-691 Reduced 4.26%	15,521 $4.48 Million
Q3 2022 Oct 27, 2022	SELL	$273.83 - $305.53 $338,727 - $377,940	-1,237 Reduced 7.09%	16,212 $4.69 Million
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $227,911 - $283,773	-970 Reduced 5.27%	17,449 $4.92 Million
Q1 2022 Apr 28, 2022	SELL	$221.42 - $260.97 $298,917 - $352,309	-1,350 Reduced 6.83%	18,419 $4.81 Million
Q4 2021 Feb 07, 2022	SELL	$177.01 - $223.45 $1.25 Million - $1.58 Million	-7,086 Reduced 26.39%	19,769 $4.34 Million
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $1.14 Million - $1.28 Million	-6,306 Reduced 19.02%	26,855 $4.87 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $2.58 Million - $3.04 Million	-13,751 Reduced 29.31%	33,161 $6.69 Million
Q1 2021 May 07, 2021	SELL	$207.02 - $241.31 $8.81 Million - $10.3 Million	-42,535 Reduced 47.55%	46,912 $10.1 Million
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $8.06 Million - $10.8 Million	-38,958 Reduced 30.34%	89,447 $21.1 Million
Q3 2020 Oct 29, 2020	SELL	$255.65 - $303.1 $259,996 - $308,252	-1,017 Reduced 0.79%	128,405 $34.9 Million
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $9.58 Million - $12.6 Million	42,505 Added 48.9%	129,422 $37.6 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $5.52 Million - $6.85 Million	27,636 Added 46.62%	86,917 $20.7 Million
Q4 2019 Feb 05, 2020	BUY	$166.71 - $223.91 $9.53 Million - $12.8 Million	57,190 Added 2735.05%	59,281 $13 Million
Q3 2019 Nov 04, 2019	SELL	$166.23 - $187.09 $38,232 - $43,030	-230 Reduced 9.91%	2,091 $354,000
Q2 2019 Aug 01, 2019	SELL	$164.61 - $190.37 $3,127 - $3,617	-19 Reduced 0.81%	2,321 $426,000
Q1 2019 May 08, 2019	SELL	$163.73 - $194.7 $982 - $1,168	-6 Reduced 0.26%	2,340 $430,000
Q4 2018 Jan 30, 2019	BUY	$151.91 - $192.21 $7,899 - $9,994	52 Added 2.27%	2,346 $389,000
Q3 2018 Nov 08, 2018	SELL	$167.73 - $192.74 $71,956 - $82,685	-429 Reduced 15.75%	2,294 $442,000
Q2 2018 Aug 08, 2018	BUY	$145.72 - $169.96 $62,076 - $72,402	426 Added 18.55%	2,723 $463,000
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $33,806 - $39,499	223 Added 10.75%	2,297 $374,000
Q4 2017 Feb 08, 2018	SELL	$137.28 - $155.55 $334,963 - $379,542	-2,440 Reduced 54.05%	2,074 $311,000
Q3 2017 Nov 02, 2017	SELL	$148.13 - $162.24 $10,813 - $11,843	-73 Reduced 1.59%	4,514 $686,000
Q2 2017 May 14, 2018	BUY	N/A	232 Added 5.33%	4,587 $591,000
Q1 2017 May 14, 2018	SELL	N/A	-210 Reduced 4.6%	4,355 $476,000
Q4 2016 May 14, 2018	BUY	N/A	4,565	4,565 $336,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Vertex Pharmaceuticals Inc Transaction History